A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China
Abstract
BACKGOUND
The spread of Coronavirus Disease 2019 (COVID-19) had been controlled in China. The seroprevalence of COVID-19 in Beijing has not been evaluated.
METHODS
In April, residents in Beijing were randomly enrolled. Blood samples were collected and antibodies to SARS- CoV-2 were tested by two colloidal gold kits. All colloidal gold positive serums were then tested by Micro- neutralization assay.
RESULTS
None of 2,184 residents participated was tested positive by micro-neutralization assay. The seroprevalence of COVID-19 in Beijing was estimated < 0.17%.
CONCLUSIONS
The seroprevalence of COVID-19 was low in April suggesting that community-wide spread was prevented in Beijing.
Related articles
Related articles are currently not available for this article.